UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease

Brum, Wagner S; de Bastiani, Marco Antônio; Bieger, Andrei; Therriault, Joseph; Ferrari-Souza, João P; Benedet, Andréa L; Saha-Chaudhuri, Paramita; ... Alzheimer's Disease Neuroimaging Initiative (ADNI); + view all (2022) A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease. Alzheimer's and Dementia: Translational Research and Clinical Interventions , 8 (1) , Article e12270. 10.1002/trc2.12270. Green open access

[thumbnail of A D Transl Res   Clin Interv - 2022.pdf]
Preview
Text
A D Transl Res Clin Interv - 2022.pdf - Published Version

Download (2MB) | Preview

Abstract

INTRODUCTION: Alzheimer's disease consensus recommends biomarker dichotomization, a practice with well-described clinical strengths and methodological limitations. Although neuroimaging studies have explored alternative biomarker interpretation strategies, a formally defined three-range approach and its prognostic impact remains under-explored for cerebrospinal fluid (CSF) biomarkers . METHODS: With two-graph receiver-operating characteristics based on different reference schemes, we derived three-range cut-points for CSF Elecsys biomarkers. According to baseline CSF status, we assessed the prognostic utility of this in predicting risk of clinical progression and longitudinal trajectories of cognitive decline and amyloid-beta (Aβ) positron emission tomography (PET) accumulation in non-demented individuals (Alzheimer's Disease Neuroimaging Initiative [ADNI]; n = 1246). In all analyses, we compared herein-derived three-range CSF cut-points to previously described binary ones. RESULTS: In our main longitudinal analyses, we highlight CSF p-tau181/Aβ1-42 three-range cut-points derived based on the cognitively normal Aβ-PET negative versus dementia Aβ-PET positive reference scheme for best depicting a prognostically relevant biomarker abnormality range. Longitudinally, our approach revealed a divergent intermediate cognitive trajectory undetected by dichotomization and a clearly abnormal group at higher risk for cognitive decline, with power analyses suggesting the latter group as potential trial enrichment candidates. Furthermore, we demonstrate that individuals with intermediate-range CSF status have similar rates of Aβ deposition to those in the clearly abnormal group. DISCUSSION: The proposed approach can refine clinico-biological prognostic assessment and potentially enhance trial recruitment, as it captures faster biomarker-related cognitive decline in comparison to binary cut-points. Although this approach has implications for trial recruitment and observational studies, further discussion is needed regarding clinical practice applications.

Type: Article
Title: A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/trc2.12270
Publisher version: https://doi.org/10.1002/trc2.12270
Language: English
Additional information: © 2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: Alzheimer's disease, CSF biomarkers, cut‐points, prognostic modeling, three‐range
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery.ucl.ac.uk/id/eprint/10147342
Downloads since deposit
210Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item